Study design

retrospective

Study time

2015.3-2019.3

Country

China

Object

1) receiving RARP or LRP for localized PCa; 2) PV ≥50 ml calculated by transrectal ultrasound; and 3) absence of any clinical evidence of positive lymph nodes or T3–T4 stage. 

Inclusion criteria

 patients failing to satisfy at least one of these criteria were excluded from the study

Sample size

231

Topic classification

Comparison of surgical techniques

Keypoint

For surgically maging localized PCa with a large prostate (≥50 ml), RARP had a tendency toward a lower risk of postoperative complications and better functiol preservation without cancer control being compromised when compared to LRP.

Year